Rafferty Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,742
| Closed | -$816K | – | 1338 |
|
|
2021
Q4 | $816K | Buy |
2,742
+1,042
| +61% | +$310K | ﹤0.01% | 962 |
|
|
2021
Q3 | $980K | Sell |
1,700
-1,280
| -43% | -$738K | 0.01% | 834 |
|
|
2021
Q2 | $1.35M | Sell |
2,980
-261
| -8% | -$119K | 0.01% | 792 |
|
|
2021
Q1 | $1.74M | Buy |
3,241
+2,946
| +999% | +$1.59M | 0.01% | 659 |
|
|
2020
Q4 | $260K | Buy |
+295
| New | +$260K | ﹤0.01% | 882 |
|